Search - tctmd.com

Displaying 1 - 20 of 122

Sort: Relevancy | Date

News Daily News

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Michael O'Riordan

December 25, 2017

News Daily News

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Caitlin E. Cox

December 21, 2017

News Daily News

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Caitlin E. Cox

December 13, 2017

News Daily News

Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures

L.A. McKeown

December 08, 2017

News Industry News

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

December 06, 2017

News Daily News

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

L.A. McKeown

December 05, 2017

News Daily News

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Caitlin E. Cox

November 30, 2017

News Conference News AHA 2017

Patients Commonly Get High Radiation Doses During CTO PCI

Todd Neale

November 20, 2017

News Conference News AHA 2017

Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs

Yael L. Maxwell

November 16, 2017

News Conference News AHA 2017

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

Todd Neale

November 12, 2017

News Conference News AHA 2017

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Shelley Wood

November 12, 2017

News Conference News AHA 2017

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Todd Neale

November 12, 2017

News Conference News TCT 2017

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

Yael L. Maxwell

November 09, 2017

News Conference News TCT 2017

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

TCT Daily Staff

November 06, 2017

News Conference News TCT 2017

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

Yael L. Maxwell

November 02, 2017

Presentation TCT 2017

CIN Risk Prediction and Contrast Volume: Data and Guidelines

Presenter: Patricia J. Best, Somjot S. Brar, Hitinder S. Gurm

November 01, 2017

News Conference News TCT 2017

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Yael L. Maxwell

November 01, 2017

News Opinion Editor's Corner TCT 2017

Live From Denver: TCT 2017, Day Three

Shelley Wood

November 01, 2017

Presentation TCT 2017

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Presenter: James E. Udelson

November 01, 2017

News Opinion Off Script TCT 2017

Off Script: Focusing on the Future

Kwan S. Lee

October 31, 2017

Advertisement

Competitive Triathletes Show Evidence of Myocardial Fibrosis

Surgical Aortic Valve Repair Effective, Durable in Experienced Hands

Isolated Tricuspid Valve Surgery Remains Rare and Risky

Ditching Desflurane Could Help Reduce Carbon Footprint of Surgical Procedures

The Lancet Publishes Twelve-Month Results for DESSOLVE III Highlighting MiStent® Performance in All-Comers Randomized Trial

Dreams Dashed: Intravascular Therapy for MS Flops in Sham-Controlled Trial

New-Generation TAVR Devices Outperform Predecessors in Treating Pure Native AR: Registry

Patients Commonly Get High Radiation Doses During CTO PCI

Reimbursement Remedy Backfires: Stress Tests Have Shifted From Private Practice to Hospitals, Driving Up Costs

PRESERVE Puts the Kibosh on Approaches to Preventing Contrast-Associated AKI

TRICS III: Restrictive Red-Cell Transfusion Noninferior to Liberal Use in Cardiac Surgery

Better PCI Outcomes Not Guaranteed at Top-Ranked Hospitals

Selection Bias? Debate Asks How Many TAVR Devices Centers Should Stock

MAVERIC: Transcatheter MV Repair Shows Continued Efficacy, Safety at 6 Months

For ‘Torrential’ Tricuspid Regurgitation, Two New Transcatheter Devices Safe, Effective in Early Results

CIN Risk Prediction and Contrast Volume: Data and Guidelines

TRACER: Novel Device Effective in Reducing Severe Degenerative MR Over 6 Months

Live From Denver: TCT 2017, Day Three

Are LV Volumes and Remodeling Suitable Endpoints for Heart Failure Drug and Device Trials?

Off Script: Focusing on the Future

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content